About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials in Texas | 1,133 Studies

Clinical Trials LymphomaTexas

Lymphoma Clinical Trials in Texas

Find 1,133 clinical trials for lymphoma near Texas. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 81-100 of 1,133 trials

Active not recruitingSafety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)The purpose of this trial is to measure the safety and effectiveness of epcoritamab (EPKINLY™), either by itself or together with other therapies, when treating participants with…NCT04663347·Birmingham, Alabama and 56 others

PreviousPage 5 of 57Next

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedDenintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular LymphomaThis is a Phase 2 study to evaluate the combination of denintuzumab mafodotin in combination with RCHOP or RCHP compared with RCHOP alone as front-line therapy in patients with…NCT02855359·Birmingham, Alabama and 34 others

Completed17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's LymphomaThis phase II trial is studying how well 17-AAG works in treating patients with relapsed or refractory anaplastic large cell lymphoma, mantle cell lymphoma, or Hodgkin's lymphoma.NCT00117988·Houston, Texas

CompletedStudy of MLN8237 in Participants With Advanced Hematological MalignanciesThis is an open-label, multicenter, phase 1 study of MLN8237 in participants with advanced hematological malignancies for whom there are limited standard treatment options.NCT00697346·Scottsdale, Arizona and 9 others

CompletedStudy Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin In Subjects With Non-Hodgkin's LymphomaThis is a phase 1 trial designed to evaluate safety and tolerability of chemotherapy in combination with inotuzumab ozogamicin, an investigational product, in adults with…NCT01055496·Gainesville, Florida and 27 others

CompletedStudy of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell LymphomaThe purpose of this study is to establish the safety and optimal dose of orally administered PCI-32765 in patients with recurrent B cell lymphoma.NCT00849654·Palo Alto, California and 8 others

CompletedPharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid MalignanciesThe goal of the clinical research study is to find the highest tolerable dose of nelarabine when given as a continuous infusion to patients with a lymphoid malignancy that has not…NCT01094860·Houston, Texas

TerminatedGiving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin DiseaseSubjects have a type of lymph gland cancer called Hodgkin or non-Hodgkin Lymphoma, which has come back or not gone away after treatment, including the best treatment we know for…NCT00058773·Houston, Texas and 1 other

Active not recruitingTargeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)This phase II Pediatric MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors…NCT03155620·Birmingham, Alabama and 171 others

CompletedINCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112)The purpose of this study is to evaluate the safety and tolerability of parsaclisib when combined with rituximab, bendamustine and rituximab, or ibrutinib in participants with…NCT03424122·Tucson, Arizona and 20 others

CompletedA Study of INCB050465 in Relapsed or Refractory Follicular LymphomaThe purpose of this study is to assess the objective response rate of parsaclisib treatment in participants with relapsed or refractory follicular lymphoma.NCT03126019·Phoenix, Arizona and 82 others

CompletedSafety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to RituximabSUMMARY: This is a multi-center open label study to evaluate the safety and effectiveness of Treanda™ (also known as bendamustine HCl or SDX-105) in patients who have indolent…NCT00139841·Birmingham, Alabama and 39 others

RecruitingPaper-Based and Smartphone-Based Memory SupportsAlzheimer's disease and related dementias lead to marked declines in daily functioning, independence, and quality of life.NCT06444841·Austin, Texas and 2 others

RecruitingPersonalized NK Cell Therapy in CBTThis phase II clinical trial studies how well personalized natural killer (NK) cell therapy works after chemotherapy and umbilical cord blood transplant in treating patients with…NCT02727803·Houston, Texas

CompletedStudy of Safety and Efficacy of BCL201 and Idelalisib in Patients With FL and MCLThis is a phase Ib multi-center, open-label study: escalation part followed by expansion part.NCT02603445·New York, New York and 6 others

CompletedAza-SAHA-GBM With AutoSCT for Refractory LymphomaThe goal of this clinical research study is to find the highest tolerable dose of azacitidine that can be given with vorinostat, gemcitabine, busulfan, and melphalan, with a stem…NCT01983969·Houston, Texas

CompletedBone Marrow Transplantation in Treating Patients With LymphomaRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00002829·Houston, Texas

RecruitingEvaluate the Safety and Clinical Activity of HH2853This is an open-label, multicenter, first-in-human phase I/II study which is composed of 3 parts: phase I dose escalation, phase I dose extension and phase II.NCT04390737·Phoenix, Arizona and 24 others

TerminatedPhase I/II Study of hLL1-DOX in Relapsed NHL and CLLThe primary objectives are to evaluate the safety and tolerability of hLL1-DOX, and to determine the maximum tolerated dose (MTD) regimen (in terms of a dose and its associated…NCT01585688·Newark, Delaware and 5 others

CompletedA Safety and Preliminary Efficacy Study of CC-99282 in Combination With Obinutuzumab in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaCC-99282-CLL-001 study is a Phase IB dose escalation and expansion clinical study of CC-99282 administered in combination with Obinutuzumab in subjects with relapsed or refractory…NCT04434196·Boston, Massachusetts and 14 others

Other Conditions in Texas

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia